Works matching IS 03682811 AND DT 2024 AND VI 54 AND IP 3

Results: 19
    1
    2
    3
    4
    5

    Investigation of a practical assessment index to capture the clinical presentation of cachexia in patients with lung cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 305, doi. 10.1093/jjco/hyad177
    By:
    • Katsushima, Utae;
    • Hase, Kimitaka;
    • Fukushima, Takuya;
    • Kubo, Takanari;
    • Nakano, Jiro;
    • Ogushi, Naoya;
    • Okuno, Yukiko;
    • Kamisako, Keisuke;
    • Nakanishi, Kentaro;
    • Okazaki, Yuta;
    • Ikoma, Tatsuki;
    • Takeyasu, Yuki;
    • Yamanaka, Yuta;
    • Yoshioka, Hiroshige;
    • Imai, Yoshie;
    • Kurata, Takayasu
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 329, doi. 10.1093/jjco/hyad170
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Ohmori, Chihiro;
    • Takamatsu, Norimi;
    • Itami, Yoshitaka;
    • Tachibana, Akira;
    • Matsumoto, Yoshihiro;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Yamamoto, Hiroaki;
    • Okajima, Eijiro;
    • Masaomi, Kuwata;
    • Sakamoto, Keichi;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    13
    14
    15
    16

    Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01).

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 319, doi. 10.1093/jjco/hyad162
    By:
    • Uryu, Kiyoaki;
    • Imamura, Yoshinori;
    • Shimoyama, Rai;
    • Mase, Takahiro;
    • Fujimura, Yoshiaki;
    • Hayashi, Maki;
    • Ohtaki, Megu;
    • Otani, Keiko;
    • Hibino, Makoto;
    • Horiuchi, Shigeto;
    • Fukui, Tomoya;
    • Fukai, Ryuta;
    • Chihara, Yusuke;
    • Iwase, Akihiko;
    • Yamada, Noriko;
    • Tamura, Yukihiro;
    • Harada, Hiromasa;
    • Shinozaki, Nobuaki;
    • Tsuya, Asuka;
    • Fukuoka, Masahiro
    Publication type:
    Article
    17
    18
    19

    A comparison of the incidence of ≥ grade 2 radiation pneumonitis between intensity-modulated radiotherapy and three-dimensional conformal radiotherapy in patients with unresectable non-small cell lung cancer treated with durvalumab after concurrent chemoradiotherapy

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 312, doi. 10.1093/jjco/hyad158
    By:
    • Masuo, Masahiro;
    • Shinohara, Eiko;
    • Kitano, Masataka;
    • Maruta, Ryusuke;
    • Chonabayashi, Satoshi;
    • Endo, Shun;
    • Matumoto, Suhei;
    • Nishiyama, Naoki;
    • Machitori, Yumiko;
    • Kobayashi, Masayoshi
    Publication type:
    Article